나스닥 바이오텍 인덱스 NBI 포함 종목들 2/19~3/23 수익률
제약-바이오 섹터/섹터
2020. 3. 26. 03:15
반응형
반응형
미국 주식시장이 단기 바닥을 형성하는 모습을 보이고 있습니다. 지금 위치에서 더 하락할 수도 있겠지만 일단은 한번 멈추는 모습을 보이고 있는 것 같습니다. 언제가 바닥일지는 아무도 모르고, 바닥 후에 어떤 모습을 보일지 역시 아무도 알 수 없습니다. 하지만 지금 시기에 미리 옥석을 가려 놓는 작업을 하는 것이 개미들이 할 수 있는 유일한 일이 아닐까 싶습니다. 가장 간단히 시작할 수 있는 방법은 급격한 하락장 동안 잘 버텨준 종목을 골라내는 일일 것 같습니다.
아래 표는 미국 주식시장이 고점을 형성했던 2/19 부터 단기 저점으로 보이는 3/23까지 나스닥 바이오텍 인덱스 (NBI)에 포함된 200여 종목들의 수익률입니다. 표 중간 중간에 NBI, XBI, S&P500, DOW30, Nasdaq 등의 수익률 역시 포함되어 있으니 비교해서 보시면 좋을 것 같습니다 (굵은 글씨로 표기). 이 기간 강세를 보였던 종목들 중에는 특별한 이벤트가 있었던 종목도 있고, 코로나-19 백신/치료제 개발에 뛰어든 기업들도 있습니다. 인수합병됐거나, 인수합병 소문이 도는 기업들도 있고, 중요한 임상시험 결과 발표를 목전에 둔 기업들도 있습니다. 개별 종목들이 강세를 보였던 이유는 각자가 찾아보시면 좋을 것 같네요. 제 블로그를 검색해 보시면 이유가 나오는 종목들도 있을 겁니다.
| 심볼 | 이름 | 시총 ($) | 수익률 | 3/23/2020 | 2/19/2020 |
| FTSV | Forty Seven Inc | 4.5B | 95.56% | 92.99 | 47.55 |
| INO | Inovio Pharmaceuticals Inc | 991.5M | 73.75% | 6.62 | 3.81 |
| MRNA | Moderna Inc | 9.1B | 40.43% | 26.57 | 18.92 |
| TBIO | Translate Bio Inc | 591.9M | 28.30% | 10.29 | 8.02 |
| WVE | Wave Life Sciences Ltd | 342.1M | 16.88% | 10.11 | 8.65 |
| REGN | Regeneron Pharmaceuticals Inc | 49.1B | 13.68% | 455.63 | 400.81 |
| KPTI | Karyopharm Therapeutics Inc | 1.5B | 12.01% | 18.28 | 16.32 |
| GILD | Gilead Sciences, Inc. | 89.7B | 7.81% | 72.61 | 67.35 |
| SRRK | Scholar Rock Holding Corp | 413.4M | 3.29% | 14.75 | 14.28 |
| LMNX | Luminex Corporation | 1.2B | 0.13% | 23.88 | 23.85 |
| RARX | Ra Pharmaceuticals Inc | 2.2B | -3.08% | 45.36 | 46.8 |
| IOVA | Iovance Biotherapeutics Inc | 3.9B | -4.34% | 23.81 | 24.89 |
| CBPO | China Biologic Products Holdings Inc | 4.2B | -5.49% | 110.21 | 116.61 |
| MCRB | Seres Therapeutics Inc | 269.6M | -5.82% | 3.4 | 3.61 |
| SIGA | SIGA Technologies, Inc. | 381.2M | -8.80% | 4.56 | 5 |
| ALLK | Allakos Inc | 2.8B | -10.99% | 56.62 | 63.61 |
| TBPH | Theravance Biopharma Inc | 1.5B | -11.23% | 22.46 | 25.3 |
| OPK | Opko Health Inc. | 954.5M | -12.50% | 1.4 | 1.6 |
| UBX | Unity Biotechnology Inc | 283.8M | -13.01% | 5.55 | 6.38 |
| EIDX | Eidos Therapeutics Inc | 1.7B | -13.29% | 45 | 51.9 |
| ENTA | Enanta Pharmaceuticals Inc | 941.6M | -13.91% | 45.93 | 53.35 |
| NTLA | Intellia Therapeutics Inc | 660.1M | -14.42% | 11.99 | 14.01 |
| TWST | Twist Bioscience Corp | 1.1B | -15.05% | 24.16 | 28.44 |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 350.9M | -15.61% | 4.81 | 5.7 |
| GERN | Geron Corporation | 214.4M | -16.15% | 1.09 | 1.3 |
| AMGN | Amgen, Inc. | 117.7B | -16.61% | 185.93 | 222.96 |
| SGEN | Seattle Genetics, Inc. | 18.3B | -17.20% | 99.27 | 119.89 |
| DRNA | Dicerna Pharmaceuticals Inc | 1.3B | -17.42% | 16.78 | 20.32 |
| ANAB | AnaptysBio Inc | 378.7M | -17.45% | 12.82 | 15.53 |
| VRTX | Vertex Pharmaceuticals Incorporated | 56.8B | -18.39% | 202.21 | 247.78 |
| OMER | Omeros Corporation | 605.5M | -18.45% | 10.96 | 13.44 |
| CSTL | Castle Biosciences Inc | 472.8M | -19.08% | 25.79 | 31.87 |
| FIXX | Homology Medicines Inc | 755.3M | -19.13% | 15.18 | 18.77 |
| TECH | BIO-TECHNE Corp | 6.7B | -19.14% | 170.34 | 210.65 |
| FOLD | Amicus Therapeutics, Inc. | 2.5B | -19.52% | 8.7 | 10.81 |
| IRWD | Ironwood Pharmaceuticals, Inc. | 1.7B | -19.53% | 9.6 | 11.93 |
| SYRS | Syros Pharmaceuticals Inc | 241.3M | -19.94% | 5.74 | 7.17 |
| ALEC | Alector Inc | 1.9B | -20.26% | 23.81 | 29.86 |
| ARGX | argenx SE - ADR | 5.1B | -20.31% | 129 | 161.88 |
| HALO | Halozyme Therapeutics, Inc. | 2.4B | -20.55% | 16.82 | 21.17 |
| BMRN | BioMarin Pharmaceutical Inc. | 14.8B | -20.59% | 71.37 | 89.87 |
| ADMA | ADMA Biologics Inc | 259.5M | -20.93% | 3.06 | 3.87 |
| BIIB | Biogen Inc | 52.1B | -21.07% | 269.19 | 341.04 |
| NBI | NASDAQ Biotechnology Index | NA | -21.21% | 3056.57 | 3879.56 |
| ALXN | Alexion Pharmaceuticals, Inc. | 19.0B | -21.39% | 81.13 | 103.21 |
| UTHR | United Therapeutics Corporation | 4.1B | -21.48% | 83.95 | 106.92 |
| SGMO | Sangamo Therapeutics Inc | 750.7M | -21.55% | 5.86 | 7.47 |
| ILMN | Illumina, Inc. | 37.4B | -21.58% | 237.76 | 303.2 |
| XNCR | Xencor Inc | 1.7B | -21.96% | 27.61 | 35.38 |
| BPMC | Blueprint Medicines Corp | 3.3B | -22.15% | 51.32 | 65.92 |
| CBAY | CymaBay Therapeutics Inc | 114.0M | -22.29% | 1.36 | 1.75 |
| CHMA | Chiasma Inc | 156.0M | -22.37% | 3.54 | 4.56 |
| KOD | Kodiak Sciences Inc | 2.2B | -22.54% | 46.4 | 59.9 |
| ZLAB | Zai Lab Ltd | 3.9B | -22.94% | 48.47 | 62.9 |
| ALNY | Alnylam Pharmaceuticals, Inc. | 11.4B | -23.21% | 99.06 | 129 |
| INCY | Incyte Corporation | 15.5B | -23.34% | 63.18 | 82.42 |
| ACAD | ACADIA Pharmaceuticals Inc. | 5.9B | -23.65% | 35 | 45.84 |
| PRTA | Prothena Corporation PLC | 387.9M | -23.71% | 9.14 | 11.98 |
| RYTM | Rhythm Pharmaceuticals Inc | 643.3M | -23.77% | 13.98 | 18.34 |
| SNY | Sanofi SA | 52.9B | -23.94% | 38.57 | 50.71 |
| GMAB | GENMAB A/S/S ADR | 87.5B | -24.15% | 18.4 | 24.26 |
| NBIX | Neurocrine Biosciences, Inc. | 8.3B | -24.17% | 79.01 | 104.2 |
| MYL | Mylan NV | 7.6B | -24.69% | 15.74 | 20.9 |
| FATE | Fate Therapeutics Inc | 1.8B | -24.76% | 22.28 | 29.61 |
| ALLO | Allogene Therapeutics Inc | 2.5B | -24.86% | 19.01 | 25.3 |
| MRTX | Mirati Therapeutics Inc | 3.7B | -24.98% | 73.14 | 97.49 |
| XLRN | Acceleron Pharma Inc | 4.3B | -25.01% | 70.82 | 94.44 |
| KRTX | Karuna Therapeutics Inc | 1.8B | -25.28% | 71.86 | 96.17 |
| CCXI | ChemoCentryx Inc | 2.5B | -25.67% | 37.55 | 50.52 |
| PDLI | PDL BioPharma Inc | 363.4M | -25.76% | 2.68 | 3.61 |
| ARNA | Arena Pharmaceuticals, Inc. | 2.1B | -25.92% | 39.96 | 53.94 |
| BGNE | Beigene Ltd | 123.6B | -26.21% | 127.8 | 173.19 |
| EDIT | Editas Medicine Inc | 1.2B | -26.22% | 19.58 | 26.54 |
| SRPT | Sarepta Therapeutics Inc | 7.7B | -26.68% | 89.38 | 121.9 |
| EGRX | Eagle Pharmaceuticals Inc | 575.1M | -26.86% | 38.67 | 52.87 |
| MNTA | Momenta Pharmaceuticals, Inc. | 3.1B | -27.55% | 24.48 | 33.79 |
| SPPI | Spectrum Pharmaceuticals, Inc. | 268.9M | -27.87% | 2.07 | 2.87 |
| ALKS | Alkermes Plc | 2.3B | -28.01% | 13.44 | 18.67 |
| GRFS | Grifols SA - ADR ADR Class B | 17.0B | -28.26% | 18.15 | 25.3 |
| STOK | Stoke Therapeutics Inc | 680.6M | -29.09% | 19.62 | 27.67 |
| ASMB | Assembly Biosciences Inc | 472.7M | -29.45% | 14.66 | 20.78 |
| NGM | NGM Biopharmaceuticals Inc | 943.8M | -29.59% | 11.78 | 16.73 |
| EXEL | Exelixis, Inc. | 5.0B | -29.63% | 15.34 | 21.8 |
| NKTR | Nektar Therapeutics | 3.1B | -29.64% | 16.07 | 22.84 |
| ASND | Ascendis Pharma A/S | 5.5B | -29.77% | 101.25 | 144.17 |
| PRVL | Prevail Therapeutics Inc | 407.5M | -29.80% | 11.87 | 16.91 |
| SLDB | Solid Biosciences Inc | 123.0M | -29.82% | 2.33 | 3.32 |
| AKRO | Akero Therapeutics Inc | 499.0M | -30.10% | 16.56 | 23.69 |
| .IXIC | Nasdaq Composite | NA | -30.12% | 6860.67 | 9817.18 |
| LXRX | Lexicon Pharmaceuticals, Inc. | 213.9M | -30.14% | 2.04 | 2.92 |
| BCRX | BioCryst Pharmaceuticals, Inc. | 319.9M | -30.25% | 1.96 | 2.81 |
| XBI | SPDR S&P Biotech | NA | -30.28% | 68.57 | 98.35 |
| LGND | Ligand Pharmaceuticals Inc. | 1.2B | -30.43% | 70.54 | 101.39 |
| ARDX | Ardelyx Inc | 530.0M | -30.52% | 5.76 | 8.29 |
| AXSM | Axsome Therapeutics Inc | 2.4B | -30.65% | 63.91 | 92.15 |
| AMPH | Amphastar Pharmaceuticals Inc | 623.3M | -30.65% | 13.19 | 19.02 |
| GH | Guardant Health Inc | 6.5B | -30.86% | 59.92 | 86.66 |
| ARVN | Arvinas Inc | 1.6B | -30.93% | 35.13 | 50.86 |
| HZNP | Horizon Therapeutics PLC | 5.5B | -31.03% | 24.87 | 36.06 |
| BBIO | BridgeBio Pharma Inc | 3.1B | -31.22% | 24.19 | 35.17 |
| PTCT | PTC Therapeutics, Inc. | 2.6B | -31.28% | 40.79 | 59.36 |
| DTIL | Precision BioSciences Inc | 306.9M | -31.31% | 5.66 | 8.24 |
| MNKD | MannKind Corporation | 229.3M | -31.47% | 0.98 | 1.43 |
| CRSP | Crispr Therapeutics AG | 2.7B | -31.96% | 39.54 | 58.11 |
| PTGX | Protagonist Therapeutics Inc | 168.9M | -31.97% | 6 | 8.82 |
| CTMX | CytomX Therapeutics Inc | 296.2M | -32.00% | 4.93 | 7.25 |
| SUPN | Supernus Pharmaceuticals Inc | 928.0M | -32.22% | 16.51 | 24.36 |
| ADPT | Adaptive Biotechnologies Corp | 3.1B | -32.40% | 22.66 | 33.52 |
| ZGNX | Zogenix, Inc. | 1.3B | -32.56% | 20.53 | 30.44 |
| IONS | Ionis Pharmaceuticals Inc | 6.6B | -32.61% | 41.6 | 61.73 |
| OSMT | Osmotica Pharmaceuticals PLC | 225.6M | -33.22% | 3.9 | 5.84 |
| XBIT | XBiotech Inc | 292.0M | -33.26% | 9.71 | 14.55 |
| PRNB | Principia Biopharma Inc | 1.8B | -33.37% | 47.01 | 70.55 |
| CERS | Cerus Corporation | 701.4M | -33.59% | 3.46 | 5.21 |
| DCPH | Deciphera Pharmaceuticals Inc | 2.3B | -33.76% | 36.51 | 55.12 |
| .INX | S&P 500 Index | NA | -33.92% | 2237.4 | 3386.15 |
| TORC | resTORbio, Inc. | 41.0M | -34.01% | 0.97 | 1.47 |
| MYOK | Myokardia Inc | 2.4B | -34.30% | 45.14 | 68.71 |
| BCEL | Atreca Inc | 348.7M | -34.50% | 14.2 | 21.68 |
| AKCA | Akcea Therapeutics Inc | 1.4B | -34.65% | 12.05 | 18.44 |
| KURA | Kura Oncology Inc | 398.9M | -35.25% | 7.88 | 12.17 |
| PRQR | ProQR Therapeutics NV | 299.7M | -35.29% | 5.61 | 8.67 |
| TPTX | Turning Point Therapeutics Inc | 1.7B | -35.48% | 38.86 | 60.23 |
| CARA | Cara Therapeutics Inc | 593.4M | -35.62% | 11.06 | 17.18 |
| AKBA | Akebia Therapeutics Inc | 1.1B | -35.71% | 6.23 | 9.69 |
| AGIO | Agios Pharmaceuticals Inc | 2.6B | -35.82% | 34.04 | 53.04 |
| ADVM | Adverum Biotechnologies Inc | 892.4M | -35.89% | 10.38 | 16.19 |
| ARWR | Arrowhead Pharmaceuticals Inc | 3.0B | -35.94% | 25.58 | 39.93 |
| RTRX | Retrophin Inc | 577.3M | -36.00% | 10.79 | 16.86 |
| DNLI | Denali Therapeutics Inc | 1.9B | -36.07% | 16.75 | 26.2 |
| CGEN | Compugen Ltd. | 558.8M | -36.09% | 6.25 | 9.78 |
| JAZZ | Jazz Pharmaceuticals PLC | 5.6B | -36.24% | 87.74 | 137.62 |
| AVRO | Avrobio Inc | 528.2M | -36.33% | 14.39 | 22.6 |
| GWPH | GW Pharmaceuticals PLC- ADR | 33.1B | -36.43% | 80.42 | 126.5 |
| .DJI | Dow Jones Industrial Average | NA | -36.65% | 18591.93 | 29348.03 |
| CHRS | Coherus Biosciences Inc | 1.2B | -36.76% | 14.23 | 22.5 |
| QURE | Uniqure NV | 2.0B | -36.78% | 41.02 | 64.88 |
| GOSS | Gossamer Bio Inc | 666.7M | -36.79% | 9.38 | 14.84 |
| GBT | Global Blood Therapeutics Inc | 3.2B | -36.94% | 44.99 | 71.35 |
| VCYT | Veracyte Inc | 1.1B | -36.99% | 16.85 | 26.74 |
| CYTK | Cytokinetics, Inc. | 654.0M | -37.13% | 9.89 | 15.73 |
| ACIU | AC Immune SA | 422.3M | -37.15% | 5.38 | 8.56 |
| PACB | Pacific Biosciences of California | 464.0M | -37.19% | 2.82 | 4.49 |
| PSNL | Personalis Inc | 214.4M | -37.79% | 6.52 | 10.48 |
| AUPH | Aurinia Pharmaceuticals Inc | 2.4B | -37.84% | 12.45 | 20.03 |
| RARE | Ultragenyx Pharmaceutical Inc | 2.4B | -38.05% | 38.13 | 61.55 |
| MYGN | Myriad Genetics, Inc. | 1.1B | -38.07% | 12.38 | 19.99 |
| RIGL | Rigel Pharmaceuticals, Inc. | 262.1M | -38.10% | 1.43 | 2.31 |
| AFMD | Affimed NV | 126.6M | -38.18% | 1.7 | 2.75 |
| AERI | Aerie Pharmaceuticals Inc | 630.5M | -38.21% | 12.03 | 19.47 |
| MEDP | Medpace Holdings Inc | 2.7B | -38.36% | 61.82 | 100.3 |
| EPZM | Epizyme Inc | 1.6B | -38.68% | 15.44 | 25.18 |
| IMMU | Immunomedics, Inc. | 2.8B | -38.78% | 11.21 | 18.31 |
| AMAG | AMAG Pharmaceuticals, Inc. | 213.1M | -39.48% | 5.58 | 9.22 |
| VNDA | Vanda Pharmaceuticals Inc. | 509.1M | -39.78% | 8.1 | 13.45 |
| NVCR | Novocure Ltd | 6.2B | -40.42% | 57.05 | 95.75 |
| HCM | HUTCHISON CHINA/S ADR | 2.2B | -40.45% | 16.34 | 27.44 |
| TCDA | Tricida Inc | 1.1B | -40.58% | 21.32 | 35.88 |
| APLS | Apellis Pharmaceuticals Inc | 2.3B | -40.71% | 23.9 | 40.31 |
| BLUE | bluebird bio Inc | 2.7B | -41.03% | 47.44 | 80.45 |
| RDUS | Radius Health Inc | 647.0M | -41.25% | 11.68 | 19.88 |
| FGEN | FibroGen Inc | 2.8B | -41.51% | 26.73 | 45.7 |
| AMRN | Amarin Corporation plc | 4.6B | -41.71% | 10.55 | 18.1 |
| AMRS | Amyris Inc | 350.6M | -41.74% | 1.94 | 3.33 |
| COLL | Collegium Pharmaceutical Inc | 572.7M | -41.82% | 13.9 | 23.89 |
| INVA | Innoviva Inc | 1.1B | -41.83% | 8.86 | 15.23 |
| BDSI | BioDelivery Sciences International, Inc. | 324.7M | -41.87% | 3.11 | 5.35 |
| RETA | Reata Pharmaceuticals Inc | 4.8B | -42.31% | 129.25 | 224.03 |
| PRAH | PRA Health Sciences Inc | 5.0B | -42.49% | 64.14 | 111.53 |
| ICPT | Intercept Pharmaceuticals Inc | 2.1B | -42.92% | 54.93 | 96.24 |
| MGTX | MeiraGTx Holdings PLC | 412.8M | -43.31% | 9.92 | 17.5 |
| RCKT | Rocket Pharmaceuticals Inc | 821.1M | -43.61% | 13.54 | 24.01 |
| PGNX | Progenics Pharmaceuticals, Inc. | 298.8M | -43.74% | 2.56 | 4.55 |
| YMAB | Y-mAbs Therapeutics, Inc | 842.1M | -43.95% | 19.32 | 34.47 |
| PCRX | Pacira Biosciences Inc | 1.3B | -43.98% | 28.4 | 50.7 |
| ANIP | ANI Pharmaceuticals Inc Common Stock | 521.1M | -44.17% | 35.06 | 62.8 |
| VYGR | Voyager Therapeutics Inc | 337.2M | -44.38% | 7.22 | 12.98 |
| ITCI | Intra-Cellular Therapies Inc | 1.0B | -44.56% | 13.31 | 24.01 |
| GTHX | G1 Therapeutics Inc | 441.2M | -44.63% | 10.67 | 19.27 |
| GRTS | Gritstone Oncology Inc | 244.8M | -44.83% | 5.66 | 10.26 |
| NSTG | NanoString Technologies Inc | 905.6M | -44.85% | 18.63 | 33.78 |
| GLPG | GALAPAGOS NV/S ADR | 10.3B | -45.23% | 146.05 | 266.68 |
| URGN | Urogen Pharma Ltd | 378.7M | -45.79% | 16.22 | 29.92 |
| ATRA | Atara Biotherapeutics Inc | 541.8M | -46.54% | 7.89 | 14.76 |
| PBYI | Puma Biotechnology Inc | 384.4M | -47.02% | 7.38 | 13.93 |
| AXNX | Axonics Modulation Technologies Inc | 824.0M | -47.53% | 18.37 | 35.01 |
| ENDP | Endo International PLC | 873.3M | -48.24% | 3.24 | 6.26 |
| PETQ | PetIQ Inc | 606.2M | -48.25% | 18 | 34.78 |
| ORTX | Orchard Therapeutics PLC - ADR | 688.2M | -48.29% | 6.49 | 12.55 |
| RGNX | Regenxbio Inc | 1.3B | -48.38% | 27.88 | 54.01 |
| GLYC | GlycoMimetics Inc | 103.5M | -49.17% | 2.15 | 4.23 |
| AGLE | Aeglea Bio Therapeutics Inc | 135.2M | -49.27% | 4.17 | 8.22 |
| SYNH | Syneos Health Inc | 4.8B | -49.30% | 33.82 | 66.7 |
| ESPR | Esperion Therapeutics Inc | 1.0B | -49.32% | 35.75 | 70.54 |
| PGEN | Precigen Inc | 605.7M | -50.33% | 2.28 | 4.59 |
| EIGR | Eiger Biopharmaceuticals Inc | 175.8M | -50.46% | 5.89 | 11.89 |
| PTLA | Portola Pharmaceuticals Inc | 545.2M | -51.10% | 6.64 | 13.58 |
| EYPT | Eyepoint Pharmaceuticals Inc | 127.9M | -51.83% | 0.92 | 1.91 |
| RVNC | Revance Therapeutics Inc | 778.0M | -52.02% | 12.8 | 26.68 |
| RUBY | Rubius Therapeutics Inc | 377.5M | -52.48% | 4.02 | 8.46 |
| MGTA | Magenta Therapeutics Inc | 258.0M | -52.61% | 6.18 | 13.04 |
| QTRX | Quanterix Corp | 421.8M | -52.99% | 13.5 | 28.72 |
| OPTN | OptiNose Inc | 176.3M | -54.02% | 3.49 | 7.59 |
| AIMT | Aimmune Therapeutics Inc | 937.9M | -54.10% | 12.53 | 27.3 |
| ATNX | Athenex Inc | 643.2M | -54.43% | 6.74 | 14.79 |
| MGNX | MacroGenics Inc | 275.1M | -55.17% | 4.86 | 10.84 |
| IMGN | ImmunoGen, Inc. | 683.3M | -55.44% | 2.54 | 5.7 |
| INSM | Insmed Incorporated | 1.7B | -56.09% | 13.63 | 31.04 |
| AUTL | Autolus Therapeutics Ltd - ADR | 280.5M | -57.12% | 4.43 | 10.33 |
| CLLS | Cellectis SA | 388.8M | -57.99% | 7.81 | 18.59 |
| TXMD | TherapeuticsMD Inc | 339.3M | -59.17% | 0.98 | 2.4 |
| SAGE | SAGE Therapeutics Inc | 1.6B | -62.12% | 26.15 | 69.03 |
| EOLS | Evolus Inc | 149.8M | -63.75% | 3.73 | 10.29 |
| XERS | Xeris Pharmaceuticals Inc | 71.0M | -64.54% | 1.67 | 4.71 |
| FLXN | Flexion Therapeutics Inc | 317.7M | -65.99% | 5.53 | 16.26 |
| AKRX | Akorn, Inc. | 73.8M | -68.31% | 0.45 | 1.42 |
반응형
'제약-바이오 섹터 > 섹터' 카테고리의 다른 글
| NBI 구성 종목 퍼포먼스 2/19~4/9 (2) | 2020.04.12 |
|---|---|
| 바겐세일 중인 헬스케어 종목들 - Baird (2) | 2020.03.26 |
| 중국 노출이 많은 다국적 제약회사들 (4) | 2020.02.19 |
| 민주당 경선과 헬스케어 (2) | 2020.02.13 |
| Influenza virus vs Coronavirus (3) | 2020.02.02 |